MorrowALBoeroGBalanI.2024. Emerging evidence for endogenous neurosteroid modulation of pro-inflammatory and anti-inflammatory pathways that impact neuropsychiatric disease. Neurosci Biobehav Rev158:105558.
2.
PaulSMPinnaGGuidottiA.2020. Allopregnanolone: from molecular pathophysiology to therapeutics. A historical perspective. Neurobiol Stress12:100215.
3.
PinnaGPonomarevaOStalcupGLRasmussonAM. 2025. Neuroactive steroids and the pathophysiology of PTSD: biomarkers for treatment targeting. Neurosci Biobehav Rev172:106085.
4.
WilsonCARobertsonLAyreKHendonJLDawsonSBridgesC others. 2025. Brexanolone, zuranolone, and related neurosteroid GABAA receptor positive allosteric modulators for postnatal depression. Cochrane Database Syst Rev 6:CD014624.
5.
ZorumskiCFCoveyDFIzumiYEversASMaguireJLMennerickSJ. 2025. New directions in neurosteroid therapeutics in neuropsychiatry. Neurosci Biobehav Rev172:106119.
